Bridget E. Bunner

Array ( [id] => 5336788 [patent_doc_number] => 20090053252 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'BIMER OR AN OLIGOMER OF A DIMER, TRIMER, QUATROMER OR PENTAMER OF RECOMBINANT FUSION PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/131478 [patent_app_country] => US [patent_app_date] => 2008-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 18335 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053252.pdf [firstpage_image] =>[orig_patent_app_number] => 12131478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391915 [patent_doc_number] => 20100303812 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'NEUTRALIZING MONOCLONAL ANTIBODY AGAINST HUMAN DLL4' [patent_app_type] => utility [patent_app_number] => 12/599804 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 15599 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303812.pdf [firstpage_image] =>[orig_patent_app_number] => 12599804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6430693 [patent_doc_number] => 20100143336 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-10 [patent_title] => 'TOLL-LIKE RECEPTOR BINDING EPITOPE AND COMPOSITIONS FOR BINDING THERETO' [patent_app_type] => utility [patent_app_number] => 12/597724 [patent_app_country] => US [patent_app_date] => 2008-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 19192 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20100143336.pdf [firstpage_image] =>[orig_patent_app_number] => 12597724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5279170 [patent_doc_number] => 20090131302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-21 [patent_title] => 'Transient receptor potential vanilloid 1 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/082281 [patent_app_country] => US [patent_app_date] => 2008-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 10619 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20090131302.pdf [firstpage_image] =>[orig_patent_app_number] => 12082281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5495376 [patent_doc_number] => 20090263404 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-22 [patent_title] => 'Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor' [patent_app_type] => utility [patent_app_number] => 12/098220 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6949 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20090263404.pdf [firstpage_image] =>[orig_patent_app_number] => 12098220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823036 [patent_doc_number] => 20080227712 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/080606 [patent_app_country] => US [patent_app_date] => 2008-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47709 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227712.pdf [firstpage_image] =>[orig_patent_app_number] => 12080606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4845906 [patent_doc_number] => 20080182314 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'Neuronal serine threonine protein kinase' [patent_app_type] => utility [patent_app_number] => 12/079441 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12591 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20080182314.pdf [firstpage_image] =>[orig_patent_app_number] => 12079441 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4847973 [patent_doc_number] => 20080184381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-31 [patent_title] => 'SCHIZOPHRENIA-RELATED VOLTAGE-GATED ION CHANNEL GENE AND PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/050492 [patent_app_country] => US [patent_app_date] => 2008-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 69765 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0184/20080184381.pdf [firstpage_image] =>[orig_patent_app_number] => 12050492 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4676209 [patent_doc_number] => 20080213839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/075686 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 47705 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213839.pdf [firstpage_image] =>[orig_patent_app_number] => 12075686 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5272101 [patent_doc_number] => 20090075877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/075713 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 47698 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075877.pdf [firstpage_image] =>[orig_patent_app_number] => 12075713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467549 [patent_doc_number] => 20100040632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'COMPOSITION' [patent_app_type] => utility [patent_app_number] => 12/530559 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14495 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040632.pdf [firstpage_image] =>[orig_patent_app_number] => 12530559 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4880370 [patent_doc_number] => 20080153753 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'METHOD OF TREATING SIDE EFFECTS INDUCED BY THERAPEUTIC AGENTS' [patent_app_type] => utility [patent_app_number] => 12/042461 [patent_app_country] => US [patent_app_date] => 2008-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9107 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153753.pdf [firstpage_image] =>[orig_patent_app_number] => 12042461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949878 [patent_doc_number] => 20080306004 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides' [patent_app_type] => utility [patent_app_number] => 12/069560 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 47608 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306004.pdf [firstpage_image] =>[orig_patent_app_number] => 12069560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6280470 [patent_doc_number] => 20100119526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'DLL4 Signaling Inhibitors and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 12/524426 [patent_app_country] => US [patent_app_date] => 2008-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 33247 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20100119526.pdf [firstpage_image] =>[orig_patent_app_number] => 12524426 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5446059 [patent_doc_number] => 20090047285 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'Compositions and methods for diagnosing and treating cancer' [patent_app_type] => utility [patent_app_number] => 12/010421 [patent_app_country] => US [patent_app_date] => 2008-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 30882 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0047/20090047285.pdf [firstpage_image] =>[orig_patent_app_number] => 12010421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4727242 [patent_doc_number] => 20080206785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'ASSAYS FOR SENSORY MODULATORS USING A SENSORY CELL SPECIFIC G-PROTEIN ALPHA SUBUNIT' [patent_app_type] => utility [patent_app_number] => 12/014215 [patent_app_country] => US [patent_app_date] => 2008-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23590 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206785.pdf [firstpage_image] =>[orig_patent_app_number] => 12014215 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4764996 [patent_doc_number] => 20080176207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-24 [patent_title] => 'Stem cell derived factors for treating pathologic conditions' [patent_app_type] => utility [patent_app_number] => 12/008583 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 16526 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20080176207.pdf [firstpage_image] =>[orig_patent_app_number] => 12008583 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11785167 [patent_doc_number] => 09394520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-19 [patent_title] => 'Expansion of hematopoietic stem cells' [patent_app_type] => utility [patent_app_number] => 12/517885 [patent_app_country] => US [patent_app_date] => 2007-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 27 [patent_no_of_words] => 10208 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12517885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4821964 [patent_doc_number] => 20080227200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => 'Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell and hematopoietic progenitor cell, and DNA coding for the same' [patent_app_type] => utility [patent_app_number] => 11/986709 [patent_app_country] => US [patent_app_date] => 2007-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 17467 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227200.pdf [firstpage_image] =>[orig_patent_app_number] => 11986709 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8875374 [patent_doc_number] => 08470332 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-06-25 [patent_title] => 'Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR' [patent_app_type] => utility [patent_app_number] => 12/312725 [patent_app_country] => US [patent_app_date] => 2007-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 39 [patent_no_of_words] => 46876 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12312725 [rel_patent_id] =>[rel_patent_doc_number] =>)